{
    "code": "02021537",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021537",
    "time": "2016-08-05 05:21:04",
    "許可證字號": "衛署藥輸字第021537號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/06\/03",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "101\/02\/05",
    "發證日期": "86\/02\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202153701",
    "中文品名": "撲咳喘吸入劑５公絲\/２公撮",
    "英文品名": "BRICANYL NEBULISING SOLUTION FOR INHALATION 5MG\/2ML",
    "適應症": "支氣管氣喘、支氣管炎及肺氣腫所伴隨之支氣管痙攣之緩解",
    "劑型": "479吸入用液劑",
    "包裝": "盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "TERBUTALINE SULFATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": {
        "製造廠名稱": "F020040000  ASTRAZENECA PTY LTD",
        "製造廠廠址": "10-14 KHARTOUM ROAD NORTH RYDE NEW SOUTH WALES 2113 AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212002910",
            "成分名稱": "TERBUTALINE SULFATE",
            "含量描述": "2.5",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ]
}